Core Viewpoint - Jiuan Medical (002432) has experienced a slight decline in stock price, closing at 37.65 yuan, down 0.32% from the previous week, with a total market capitalization of 17.857 billion yuan as of June 6, 2025 [1] Group 1: Company Announcements - Jiuan Medical announced a 2024 annual equity distribution plan, proposing a cash dividend of 2.00 yuan per 10 shares, totaling 85.851 million yuan, with the record date on June 10, 2025, and the ex-dividend date on June 11, 2025 [2] - As of May 30, 2025, Jiuan Medical has repurchased 13,038,306 shares, accounting for 2.75% of the total share capital, with a total transaction amount of approximately 500 million yuan [3] - The company’s board approved adjustments to the stock option exercise prices for the 2020 and 2021 incentive plans, reducing the exercise price from 8.18 yuan to 8.00 yuan for 2020, and from 3.14 yuan to 2.96 yuan for 2021 [4][6] Group 2: Financing and Strategic Initiatives - Jiuan Medical plans to register and issue medium-term notes up to 3.5 billion yuan and short-term financing bonds up to 500 million yuan to optimize its debt structure [4][5][6] - The company has increased its comprehensive credit limit to no more than 10 billion yuan or equivalent foreign currency [4] - A second extraordinary general meeting of shareholders is scheduled for June 20, 2025, to discuss the proposed issuance of medium-term notes and short-term financing bonds [5]
每周股票复盘:九安医疗(002432)2024年度权益分派实施,调整股票期权行权价格